Synthesis and in vivo evaluation of the putative breast cancer resistance protein inhibitor [(11)C]methyl 4-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)amino-carbonyl)-2-(quinoline-2-carbonylamino)benzoate

類似資料

• Synthesis and in vivo evaluation of [(11)C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor
  著者:: Bauer, Florian, 等
  出版事項: (2010)
• Synthesis and small-animal positron emission tomography evaluation of [(11)C]-elacridar as a radiotracer to assess the distribution of P-glycoprotein at the blood-brain barrier
  著者:: Dörner, Bernd, 等
  出版事項: (2009)
• The antiepileptic drug mephobarbital is not transported by P-glycoprotein or multidrug resistance protein 1 at the blood-brain barrier: a positron emission tomography study
  著者:: Mairinger, Severin, 等
  出版事項: (2012)
• A novel PET protocol for visualization of breast cancer resistance protein function at the blood–brain barrier
  著者:: Wanek, Thomas, 等
  出版事項: (2012)
• 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers
  著者:: Braconi, Laura, 等
  出版事項: (2020)